Seeking Alpha

forever5683

forever5683
Send Message
View forever5683's StockTalks BY TICKER:
  • forever5683
    $OXGN I'm still LONG. Here is what I think - there were large vol. shares bought than sold per each time. And suspicious about today's stock
    Mar 20, 4:31 PM
    Reply (2)
    • forever5683: offer $10M, It's easiest way for the company to distribute shares freely or to whom they want to get benefit from their big catalyst news.
      Mar 20, 4:32 PM
    • forever5683: Believe or not, I think the news is coming soon. Even if there is not, I might have to hold it for another year.. which I don't like. LOL
      Mar 20, 4:34 PM
      • forever5683
        $OXGN I don't know what's going on, but surely, this might be a mega fish.
        Mar 12, 11:37 AM
        Reply (1)
        • pat45: Yep agreed this fish should grow
          Mar 17, 3:32 PM
          • forever5683
            $ACHN good to own it under $10~$11.
            Mar 6, 10:16 AM
            Reply (3)
          • View all 3 replies
            • forever5683: ACHN is already hammered, don't think it would go down below $10.
              Mar 6, 11:03 AM
            • Greenfire87: watch (buy) $MEIP thru march/april.
              Mar 6, 11:25 PM
              • forever5683
                $OGXI get some when it dropped. It has been growing without a major catalyst. I acquired @ $2.07 a month ago, now it's $2.50s. Good to own
                Mar 6, 10:09 AM
                Reply (1)
                • forever5683: $OGXI = LOW pt is $4 & HIGH pt $14 , I recommend owing OGXI .
                  Mar 6, 10:15 AM
                  • forever5683
                    $MNKD only thing I see from yahoo source that inside MNKD is selling more of their shares continuously at or around $6.40
                    Mar 2, 10:35 AM
                    Reply (3)
                  • View all 3 replies
                    • forever5683: If you are LONG, guess you are believing success in MNKD; If you short, then maybe a good time to be at on side and watch how it goes.
                      Mar 2, 10:40 AM
                    • forever5683: I don't hate MNKD or their Afrezza. I wish it success in the market for the patient, stock, & compnay. But I hate to lose my money ~ : ).
                      Mar 2, 10:41 AM
                      • forever5683
                        $APRI maybe this is the day for SHORTS profit taking ? rose from $2 to $2.70
                        Feb 26, 9:57 AM
                        Reply
                          • forever5683
                            $MNKD , I remain skeptical as well;
                            Feb 26, 9:54 AM
                            Reply (3)
                          • View all 3 replies
                            • forever5683: yes yes all those, But the skepticism will cause MNKD fall further below, hope that 1Q15 revenue report wouldn't disappoint all of us.
                              Feb 26, 10:47 AM
                            • forever5683: I will stand beside, take my 1 month off, or invest again if it falls below $6. Unless MNKD can release a hint of appealing profit in 1Q15
                              Feb 26, 10:50 AM
                              • forever5683
                                $OXGN 2/10, nothing new, but CEO did say they are planning to sit down with FDA regarding phase3 trial. OXgN has no fund to go it alone.
                                Feb 11, 12:48 PM
                                Reply (2)
                                • forever5683: I don't think they can do stock dilution for above $100M which is needed for phase3 trial. The only thing they can get this going
                                  Feb 11, 12:49 PM
                                • forever5683: is by Partnering or sell the company. Still taking LONG for its high potential gain, but hate the delay.
                                  Feb 11, 12:51 PM
                                  • forever5683
                                    $OXGN news soon? Lately, someone is buying whole lot of shares.
                                    Jan 8, 3:22 PM
                                    Reply (2)
                                    • Professional_Tradr: The last insider buy was all the way back in June of 2013.
                                      Jan 8, 6:15 PM
                                    • forever5683: yes & several insiders had more acquisitions and none sold in 2014, two initiated BUY in 2014, OXgN at strong buy status, price target $6.50
                                      Jan 9, 6:19 AM
                                      • forever5683
                                        $OXGN : Nov.10,2014 - OXGN confirmed that addition of Fosbretabulin to Bevacizumab SIGNIFICANTLY increase PFS in recurrent ovarian cancer
                                        12/17/14
                                        Reply (3)
                                      • View all 3 replies
                                        • forever5683: Shorter phase 3 trial or accelerate their early approval for Fosbretabulin; Inside OXGN acquiring more shares;
                                          12/17/14
                                        • forever5683: Fosbretabulin to Bevacizumab is non-chemotherapy; Its market size is worth $billion dollars; are reason for BO for OXGN in anytime soon.
                                          12/17/14
                                          • forever5683
                                            $OXGN any stock under $3 or less , easy to be manipulated. OXGN is good, if you grabbed some, then you are in a good luck.
                                            12/15/14
                                            Reply
                                              • forever5683
                                                $OXGN Dec.is, perhaps, the time for an announcement ; I think so and that those shorts would miss the ride when it happens. ; )
                                                12/2/14
                                                Reply
                                                  • forever5683
                                                    $OXGN with the approval from Roche, now expect OXGN partner or acquisition within 1~3 months. pt $5.50~$6.50
                                                    11/17/14
                                                    Reply
                                                      • forever5683
                                                        $OXGN Now with the FDA approval, OXGN has a better chance of getting their partner for 3phase.
                                                        11/14/14
                                                        Reply (1)
                                                        • forever5683: Partner news be another catalyst for OXGN, expecting its partner news within 1 month.
                                                          11/14/14
                                                          • forever5683
                                                            $OXGN http://seekingalpha.com/n/19myt
                                                            11/14/14
                                                            Reply (4)
                                                          • View all 4 replies
                                                            • forever5683: @Indian420 Let say, ROCHE's FDA approval was A+B and OXGN has A+C; A gets approved, but A+C works better than A alone, nice pathway for OX
                                                              11/14/14
                                                            • Indian420: thanks..hopefully partner news would be coming soon now..
                                                              11/15/14
                                                              • forever5683
                                                                $OXGN Pha. 2 Data Confirming - Addition of Fosbretabulin to Bevacizumab Significantly Increases Progression http://yhoo.it/1w9nAak
                                                                11/10/14
                                                                Reply
                                                                  • forever5683
                                                                    $APRI 3 upcoming conference 11/12 , 11/18, 12/4
                                                                    11/7/14
                                                                    Reply
                                                                      • forever5683
                                                                        $ICPT earning caused it to drop -20% today???
                                                                        11/7/14
                                                                        Reply (4)
                                                                      • View all 4 replies
                                                                        • Hoang6: But don't you think $5B is a bit too high for a R/D company?
                                                                          11/7/14
                                                                        • derrickthms182: Easy pick up right here. $180 has been it support a few times. Ride the wave!
                                                                          11/7/14
                                                                          • forever5683
                                                                            $AEZS BE patient, guys ~ : )
                                                                            11/4/14
                                                                            Reply (1)
                                                                            • Roids0777: I wonder when they are going to halt trading.
                                                                              11/5/14
                                                                              • forever5683
                                                                                $CNAT think it's good entry at $7. Bought
                                                                                11/3/14
                                                                                Reply